8/25/2023 | BKIG | Fitch revises Fresenius view to stable
|
8/25/2023 | BKIG | Fitch pulls Fresenius Medical from watch
|
2/27/2023 | BKHYIG | Moody’s views Fresenius negatively
|
2/27/2023 | BKHYIG | Fitch places Fresenius Medical on watch
|
2/24/2023 | BKCVHYIG | S&P moves Fresenius SE view to negative
|
2/24/2023 | BKCVHYIG | S&P cuts Fresenius Medical Care
|
11/15/2022 | CVIG | Fitch moves Fresenius view to negative
|
9/10/2020 | IG | New Issue: Fresenius Medical sells $1 billion 2.375% notes due 2031 at 170 bps over Treasuries
|
7/17/2019 | HY | Market Commentary: Medical Properties Trust upsizes drive-by; US Renal Care slips; inflows to asset managers continue
|
7/17/2019 | DD | Market Commentary: Mallinckrodt declines as ALS study permanently halted, dialysis names under scrutiny
|
6/13/2019 | IG | New Issue: Fresenius Medical sells $500 million 3.75% 10-year notes at 185 bps over Treasuries
|
4/18/2019 | BKCVIG | Fitch affirms Fresenius Medical
|
12/27/2017 | BKCVHYIG | S&P changes Fresenius view
|
8/7/2017 | BKBWCVIG | Fresenius may raise leverage by 70 basis points for NxStage purchase
|
7/12/2017 | BKHYIG | S&P lifts Fresenius notes from junk
|
7/7/2017 | HY | Moody’s cuts Imperial Metals
|
7/7/2017 | IG | Moody’s downgrades Wepco, Wisconsin Gas
|
7/7/2017 | HYIG | Moody’s upgrades Fresenius
|
5/11/2017 | BKCVHYIG | Moody’s ups Fresenius to investment-grade
|
3/23/2017 | BKHYIG | Fitch: Fresenius notes BBB-
|
9/29/2016 | BKHYIG | Moody’s rates Fresenius Holdings Ba2
|
7/29/2016 | BKHYIG | Fitch lifts Fresenius from junk
|
5/20/2015 | CV | Fresenius lowers conversion price of convertible bonds due 2020
|
3/19/2015 | BKCVHYIG | Fitch lower Fresenius view to stable
|
1/16/2015 | HY | Market Commentary: Dollar primary quiet to close $6 billion week, Europe active; Bombardier off again, Caesars up
|
1/16/2015 | BKCVHYIG | S&P ups Fresenius from junk
|
12/1/2014 | BK | Fresenius increases credit facility to $4.4 billion, extends maturity
|
10/9/2014 | CV | Fresenius sets initial conversion price for convertible bonds due 2020
|
9/16/2014 | CV | New Issue: Fresenius Medical Care prices €400 million convertible bonds to yield 1.125%, up 35%
|
8/6/2013 | BKHY | Moody's changes Fresenius view to positive, rates loan Baa3
|
6/17/2013 | BKHY | Fitch: Fresenius view to positive
|
3/28/2013 | BKHY | S&P lifts Fresenius view to positive
|
10/9/2012 | BKHY | Moody's: Fresenius facilities Baa3
|
6/18/2012 | BK | S&P: Fresenius loans BBB-; placed on watch
|
4/30/2012 | BKHY | S&P: Fresenius on watch
|
4/26/2012 | BKHY | Fitch affirms Fresenius
|
4/26/2012 | BKHY | Moody's may lower Fresenius
|
3/21/2012 | HY | New Issue: Fresenius prices €500 million seven-year notes at par to yield 41/4%
|
3/21/2012 | HY | Market Commentary: Nord Anglia, upsized Rexel price, Alliance Data on tap; Solo Cup surges on buyout
|
3/19/2012 | HY | Moody's assigns Ba1 to new Fresenius Finance notes
|
3/19/2012 | HY | Market Commentary: AK Steel prices, trades near issue; Cenveo reshapes, Poindexter, IDQ slate; Sprint stumbles
|
3/19/2012 | BKHY | S&P rates Fresenius notes BB+
|
3/19/2012 | HY | Fresenius starts roadshow for €500 million seven-year bullet notes
|
2/27/2012 | BKHY | S&P ups Fresenius, Fresenius Medical, notes
|
1/26/2012 | BKHY | Moody's: Fresenius notes Ba2
|
1/20/2012 | HY | Market Commentary: Cable & Wireless, Taminco price to end all-Europe week, trade up; market firm, Sears surges
|
1/19/2012 | HY | Market Commentary: Polkomtel prices, pops, Ardagh appears; Kodak crushed on Chapter 11; junk funds' gains go on
|
1/18/2012 | HY | New Issue: Fresenius prices €250 million 7.5-year notes at par to yield 51/4%
|
1/18/2012 | HY | Market Commentary: Fresenius sells euro notes as its new dollar bonds rise; JBS, PetroBakken slate; market firms
|
1/17/2012 | HY | Moody's: Fresenius notes Ba2
|
1/17/2012 | BK | Fresenius Medical Care to pay down term loan debt with notes proceeds
|
1/17/2012 | HY | Market Commentary: Fresenius prices upsized $1.5 billion two-part deal; forward calendar swells; energy names off
|
1/17/2012 | BK | Market Commentary: Lee trades up; CCS trims OID; Blue Coats modifies size, structure; Generac, CKx set talk
|
1/17/2012 | HY | Fresenius to price €250 million 7.5-year bullet notes on Wednesday
|
1/17/2012 | HY | New Issue: Fresenius upsizes to $1.5 billion, prices two tranches of senior notes
|
1/17/2012 | HY | S&P rates Fresenius notes
|
10/13/2011 | BKHY | Moody's: Fresenius notes Ba2
|
10/11/2011 | BKHY | S&P rates Fresenius notes BB
|
10/11/2011 | HY | New Issue: Fresenius sells €100 million five-year notes at par to yield Euribor plus 350 bps
|
10/11/2011 | HY | Market Commentary: Junk jumps as trading resumes; Levi sizzles; Sprint fizzles; Kinetic Concepts downsizes deal
|
9/14/2011 | BKHY | Moody's: Fresenius notes Ba2
|
9/8/2011 | BKHY | S&P rates Fresenius notes BB
|
9/7/2011 | BKHY | Moody's rates Fresenius notes Ba2
|
8/4/2011 | BKHYPF | Moody's: Fresenius unchanged
|
2/10/2011 | BKHYPF | S&P drops Fresenius notes
|
1/21/2011 | BKHY | Moody's rates Fresenius Medical Care notes Ba2
|
10/1/2010 | BK | Fresenius Medical extends credit facility, upsizes to $2.57 billion
|
8/24/2010 | BK | Fresenius Medical to launch revolver and term A extension on Sept. 8
|
8/3/2010 | BKHY | Fitch cuts Fresenius view to positive
|
4/29/2010 | BKHY | S&P: Fresenius view positive
|
4/27/2010 | CV | 'Short-volatility' mandatories can be important part of convertibles portfolio: analyst Epstein
|
1/22/2010 | HY | Market Commentary: Upsized Equinox, European offerings price; Blockbuster again hit as disappointing week ends
|
1/13/2010 | HY | New Issue: Fresenius prices €250 million 51/2% 6.5-year notes at 98.6636 to yield 53/4%
|
1/12/2010 | BKHY | S&P gives Fresenius notes BB+
|
1/11/2010 | BK | Market Commentary: Jarden reacts to bond news; Hexion rises; Cedar Fair launch rumored soon; Broadlane readies deal
|
1/11/2010 | BKHY | Moody's rates Fresenius notes Ba2
|
1/11/2010 | HY | Fresenius starts roadshow for €250 million 6.5-year bullet notes
|
8/17/2009 | BKHY | Fitch rates Fresenius Finance notes BB
|
5/7/2009 | BKHY | S&P: Fresenius outlook stable
|
4/30/2009 | HYPV | New Issue: Fresenius places €200 million notes at average 6.95% rate in four tranches
|
11/18/2008 | BK | Market Commentary: Precision floats OID; Harrah's dips with downgrade; GM, Ford take a hit; CLOs target good quality names
|
11/4/2008 | BK | Market Commentary: Precision Drilling sets talk; U.S. Silica cuts size; Fresenius rises with numbers; Dean Foods trades up
|
7/18/2008 | CV | New Issue: Fresenius sells reduced €554 million three-year mandatory exchangeables at 5.625%, up 18%
|
7/17/2008 | CV | Fresenius talks €600 million three-year mandatory exchangeables at 5.125%-5.625%, up 18%-22%
|
7/9/2008 | BKHY | S&P: Fresenius outlook negative
|
7/7/2008 | BK | Market Commentary: Penn National term B slides some more; Fresenius holds steady; Broadlane firms timing
|
5/20/2008 | BK | Market Commentary: Visteon up with tender; Mediacom dips on new debt; Fresenius rises; airlines, autos under pressure
|
5/13/2008 | BKHY | S&P: Fresenius view positive
|
2/20/2008 | BK | Market Commentary: Rock-Tenn to upsize; 84 Lumber nets orders; Fresenius up on numbers; TXU slides
|
7/31/2007 | BKHY | Fitch affirms Fresenius
|